Our findings revealed a consistent elevation in SIGLEC7 expression across multiple tumor types, notably in LGG and GBM tissues, indicating a potential oncogenic role of SIGLEC7 in gliomas (Supplementary Figure 1). This evidence concerns the gene SIGLEC7 and central nervous system cancer.